The biology is real, the pharmaceutical investment is enormous, and the pipeline keeps escalating from GLP-1, to dual agonists, to triple agonists like retatrutide, with each generation producing results that would have seemed impossible a decade ago
Falutz, J., et al., Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation
Cardiol Rev
Future prospective trials are needed to establish evidence-based guidelines for AWE management and refine the selection of the most appropriate ablation method [23, 25,26,27]
By promoting collagen production and improving blood flow to injured areas, it aids in faster recovery from injuries and enhanced mobility during the aging process